Correlation Between Molson Coors and Vertex Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Molson Coors and Vertex Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molson Coors and Vertex Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Molson Coors Beverage and Vertex Pharmaceuticals Incorporated, you can compare the effects of market volatilities on Molson Coors and Vertex Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molson Coors with a short position of Vertex Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molson Coors and Vertex Pharmaceuticals.

Diversification Opportunities for Molson Coors and Vertex Pharmaceuticals

0.71

Correlation Coefficient

Molson Coors  Vertex Pharmaceuticals

Poor diversification

The 3 months correlation between Molson and Vertex is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Molson Coors Beverage and Vertex Pharmaceuticals Incorpo in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vertex Pharmaceuticals and Molson Coors is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molson Coors Beverage are associated (or correlated) with Vertex Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vertex Pharmaceuticals has no effect on the direction of Molson Coors i.e., Molson Coors and Vertex Pharmaceuticals go up and down completely randomly.

Pair Corralation between Molson Coors and Vertex Pharmaceuticals

Assuming the 90 days trading horizon Molson Coors is expected to generate 1.06 times less return on investment than Vertex Pharmaceuticals. But when comparing it to its historical volatility, Molson Coors Beverage is 1.24 times less risky than Vertex Pharmaceuticals. It trades about 0.19 of its potential returns per unit of risk. Vertex Pharmaceuticals Incorporated is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest  62,977  in Vertex Pharmaceuticals Incorporated on December 24, 2024 and sell it today you would earn a total of  8,943  from holding Vertex Pharmaceuticals Incorporated or generate 14.2% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Molson Coors Beverage  vs.  Vertex Pharmaceuticals Incorpo

Molson Coors Beverage

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Molson Coors Beverage are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak fundamental indicators, Molson Coors sustained solid returns over the last few months and may actually be approaching a breakup point.

Vertex Pharmaceuticals

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Vertex Pharmaceuticals Incorporated are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Vertex Pharmaceuticals sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Molson Coors and Vertex Pharmaceuticals

The main advantage of trading using opposite Molson Coors and Vertex Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molson Coors position performs unexpectedly, Vertex Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vertex Pharmaceuticals will offset losses from the drop in Vertex Pharmaceuticals' long position.

The idea behind Molson Coors Beverage and Vertex Pharmaceuticals Incorporated pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.